
89bio Inc is a biotechnology business based in the US. 89bio shares (ETNB) are listed on the NASDAQ and all prices are listed in US Dollars. 89bio employs 41 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in 89bio
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ETNB – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Our top pick for
Beginners

Our top pick for
Building a portfolio

Our top pick for
Active traders

89bio stock price (NASDAQ: ETNB)
Use our graph to track the performance of ETNB stocks over time.89bio shares at a glance
Latest market close | $3.02 |
---|---|
52-week range | $2.00 - $21.47 |
50-day moving average | $2.95 |
200-day moving average | $9.12 |
Wall St. target price | $26.63 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-5.00 |
Buy 89bio shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy 89bio stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
89bio price performance over time
Historical closes compared with the close of $3.02 from 2022-07-05
1 week (2022-06-28) | -14.93% |
---|---|
1 month (2022-06-06) | -15.88% |
3 months (2022-04-06) | -16.34% |
6 months (2022-01-06) | -76.20% |
1 year (2021-07-06) | -82.15% |
---|---|
2 years (2020-07-06) | -88.60% |
3 years (2019-07-02) | N/A |
5 years (2017-07-02) | N/A |
89bio financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -37.42% |
Return on equity TTM | -68.89% |
Profit margin | 0% |
Book value | $5.05 |
Market capitalisation | $65.9 million |
TTM: trailing 12 months
89bio share dividends
We're not expecting 89bio to pay a dividend over the next 12 months.
89bio share price volatility
Over the last 12 months, 89bio's shares have ranged in value from as little as $2 up to $21.47. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while 89bio's is 1.7234. This would suggest that 89bio's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
89bio overview
89bio, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also intends to develop pegozafermin for the treatment of severe hypertriglyceridemia. 89bio, Inc. was incorporated in 2018 and is headquartered in San Francisco, California. .
89bio in the news
What Kind Of Shareholders Hold The Majority In 89bio, Inc.'s (NASDAQ:ETNB) Shares?
89bio Announces Closing of its Upsized $94.5 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants
89bio Announces Closing of its Upsized $94.5 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants
Frequently asked questions
What percentage of 89bio is owned by insiders or institutions?Currently 0.927% of 89bio shares are held by insiders and 87.422% by institutions. How many people work for 89bio?
Latest data suggests 41 work at 89bio. When does the fiscal year end for 89bio?
89bio's fiscal year ends in December. Where is 89bio based?
89bio's address is: 142 Sansome Street, San Francisco, CA, United States, 94104 What is 89bio's ISIN number?
89bio's international securities identification number is: US2825591033 What is 89bio's CUSIP number?
89bio's Committee on Uniform Securities Identification Procedures number is: 282559103
More guides on Finder
-
How to buy Citrine Global (CTGL) stock when it goes public
Everything we know about the Citrine Global IPO, plus information on how to buy in.
-
How to buy Genelux Corporation (GNLX) stock when it goes public
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
-
How to buy Magic Empire Global (MEGL) stock when it goes public
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Ask an Expert